Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · IEX Real-Time Price · USD
1.480
+0.080 (5.71%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Lineage Cell Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1996
Cash & Equivalents
35.4411.3655.7432.599.523.5936.8422.0942.2329.49
Upgrade
Short-Term Investments
0.0546.522.628.9844.847.151.340.630.750
Upgrade
Cash & Cash Equivalents
35.4957.8858.3641.5654.3330.7438.1822.7242.9829.49
Upgrade
Cash Growth
-38.67%-0.83%40.41%-23.50%76.74%-19.47%68.06%-47.15%45.75%424.30%
Upgrade
Receivables
0.750.350.8400.323.723.051.161.651.42
Upgrade
Inventory
0000000000.27
Upgrade
Other Current Assets
2.21.832.352.432.861.91.41.782.611.23
Upgrade
Total Current Assets
38.4460111.554457.5236.3642.6225.6547.2432.41
Upgrade
Property, Plant & Equipment
4.775.674.875.638.185.845.535.537.542.86
Upgrade
Long-Term Investments
0000055.84117.17100.044.670
Upgrade
Goodwill and Intangibles
57.2357.3657.4957.758.923.136.910.2133.5938.85
Upgrade
Other Long-Term Assets
0.580.630.630.620.860.511.021.151.620.79
Upgrade
Total Long-Term Assets
62.5863.666363.9567.9665.3130.62116.9247.4242.5
Upgrade
Total Assets
101.02123.66174.55107.95125.48101.66173.24142.5794.6674.9
Upgrade
Accounts Payable
6.278.6127.976.815.236.465.727.149.386.8
Upgrade
Deferred Revenue
29.537.1550.570.190.250.040.80.883.890.55
Upgrade
Current Debt
0.880.950.830.761.220.310.361.130.130.06
Upgrade
Other Current Liabilities
-18.69-27.73-32.260-0.200-0.31-0.94-0.34
Upgrade
Total Current Liabilities
17.9618.9847.127.776.496.816.888.8512.467.07
Upgrade
Long-Term Debt
2.072.941.972.543.951.961.172.854.970.47
Upgrade
Other Long-Term Liabilities
18.9729.834.562.513.790.640.930.370.784.64
Upgrade
Total Long-Term Liabilities
21.0432.7536.535.057.742.62.13.215.755.11
Upgrade
Total Liabilities
3951.7383.6512.8214.239.418.9812.0618.2112.18
Upgrade
Total Debt
2.953.92.83.35.172.271.533.985.10.53
Upgrade
Debt Growth
-24.23%39.04%-15.14%-36.11%128.17%47.75%-61.50%-21.97%868.31%-
Upgrade
Retained Earnings
-384.86-363.37-337.1-294.08-273.42-261.86-216.3-196.32-229.89-182.19
Upgrade
Comprehensive Income
-3.07-3.57-5.21-3.67-0.681.430.45-0.74-0.240.19
Upgrade
Shareholders' Equity
63.4273.3492.2296.2112.9693.84162.64117.9325.8236.46
Upgrade
Net Cash / Debt
32.5453.9855.5638.2649.1628.4836.6418.7337.8828.96
Upgrade
Net Cash / Debt Growth
-39.72%-2.84%45.21%-22.18%72.65%-22.29%95.60%-50.55%30.78%414.93%
Upgrade
Net Cash Per Share
0.190.320.340.250.340.220.320.190.480.44
Upgrade
Working Capital
20.4841.0264.4336.2351.0329.5535.7416.834.7825.34
Upgrade
Book Value Per Share
0.370.430.560.640.780.741.421.210.320.55
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).